APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sclerotherapy Injection Needle

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Sclerotherapy Injection Needle Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026195 pages

Choose your research edition.

Industry ResearchSclerotherapy Injection Needle Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Sclerotherapy Injection Needle Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Sclerotherapy Injection Needle Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sclerotherapy Injection Needle Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Sclerotherapy Injection Needle Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Sclerotherapy Injection Needle market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Sclerotherapy Injection Needle is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sclerotherapy Injection Needle is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sclerotherapy Injection Needle is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sclerotherapy Injection Needle is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sclerotherapy Injection Needle include Boston Scientific, ZKSK Medical, Upex-med, TeleMed Systems, STERIS, Shaili Endoscopy, Micro-tech, Mednova Medical Technology and Jiangsu Vedkang Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sclerotherapy Injection Needle market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sclerotherapy Injection Needle and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sclerotherapy Injection Needle sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sclerotherapy Injection Needle market size, projected growth trends, production technologies, key applications, and end-use industries.

Sclerotherapy Injection Needle Segment by Company

Boston Scientific

ZKSK Medical

Upex-med

TeleMed Systems

STERIS

Shaili Endoscopy

Micro-tech

Mednova Medical Technology

Jiangsu Vedkang Medical

Endo-Therapeutics

Diagmed Healthcare

Cook Medical

Conmed Corporation

ConMed

Changzhou Jiuhong Medical

Blueneem

Sclerotherapy Injection Needle Segment by Type

21G Needle

23G Needle

24G Needle

25G Needle

Others

Sclerotherapy Injection Needle Segment by Application

Hospital

Clinic

Others

Sclerotherapy Injection Needle Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sclerotherapy Injection Needle market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sclerotherapy Injection Needle and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sclerotherapy Injection Needle.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sclerotherapy Injection Needle market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sclerotherapy Injection Needle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Sclerotherapy Injection Needle in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Sclerotherapy Injection Needle in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Sclerotherapy Injection Needle Industry Trends Table 2. Sclerotherapy Injection Needle Industry Drivers Table 3. Sclerotherapy Injection Needle Industry Opportunities and Challenges Table 4. Sclerotherapy Injection Needle Industry Restraints Table 5. Global Sclerotherapy Injection Needle Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Sclerotherapy Injection Needle Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Sclerotherapy Injection Needle Sales by Manufacturers (M units) & (2021-2026) Table 8. Global Sclerotherapy Injection Needle Sales Market Share by Manufacturers Table 9. Global Sclerotherapy Injection Needle Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Sclerotherapy Injection Needle Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Sclerotherapy Injection Needle Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Sclerotherapy Injection Needle Manufacturers, Product Type & Application Table 13. Global Sclerotherapy Injection Needle Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Sclerotherapy Injection Needle by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 21G Needle Table 17. Major Manufacturers of 23G Needle Table 18. Major Manufacturers of 24G Needle Table 19. Major Manufacturers of 25G Needle Table 20. Major Manufacturers of Others Table 21. Global Sclerotherapy Injection Needle Sales by Type 2021 VS 2025 VS 2032 (M units) Table 22. Global Sclerotherapy Injection Needle Sales by Type (2021-2026) & (M units) Table 23. Global Sclerotherapy Injection Needle Sales by Type (2027-2032) & (M units) Table 24. Global Sclerotherapy Injection Needle Sales Market Share by Type (2021-2026) Table 25. Global Sclerotherapy Injection Needle Sales Market Share by Type (2027-2032) Table 26. Global Sclerotherapy Injection Needle Revenue by Type 2021 VS 2025 VS 2032 (M units) Table 27. Global Sclerotherapy Injection Needle Revenue by Type (2021-2026) & (M units) Table 28. Global Sclerotherapy Injection Needle Revenue by Type (2027-2032) & (M units) Table 29. Global Sclerotherapy Injection Needle Revenue Market Share by Type (2021-2026) Table 30. Global Sclerotherapy Injection Needle Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Clinic Table 33. Major Manufacturers of Others Table 34. Global Sclerotherapy Injection Needle Sales by Application 2021 VS 2025 VS 2032 (M units) Table 35. Global Sclerotherapy Injection Needle Sales by Application (2021-2026) & (M units) Table 36. Global Sclerotherapy Injection Needle Sales by Application (2027-2032) & (M units) Table 37. Global Sclerotherapy Injection Needle Sales Market Share by Application (2021-2026) Table 38. Global Sclerotherapy Injection Needle Sales Market Share by Application (2027-2032) Table 39. Global Sclerotherapy Injection Needle Revenue by Application 2021 VS 2025 VS 2032 (M units) Table 40. Global Sclerotherapy Injection Needle Revenue by Application (2021-2026) & (M units) Table 41. Global Sclerotherapy Injection Needle Revenue by Application (2027-2032) & (M units) Table 42. Global Sclerotherapy Injection Needle Revenue Market Share by Application (2021-2026) Table 43. Global Sclerotherapy Injection Needle Revenue Market Share by Application (2027-2032) Table 44. Global Sclerotherapy Injection Needle Sales by Region: 2021 VS 2025 VS 2032 (M units) Table 45. Global Sclerotherapy Injection Needle Sales by Region (2021-2026) & (M units) Table 46. Global Sclerotherapy Injection Needle Sales Market Share by Region (2021-2026) Table 47. Global Sclerotherapy Injection Needle Sales Forecasted by Region (2027-2032) & (M units) Table 48. Global Sclerotherapy Injection Needle Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Sclerotherapy Injection Needle Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M units) Table 50. North America Sclerotherapy Injection Needle Sales by Country (2021-2026) & (M units) Table 51. North America Sclerotherapy Injection Needle Sales by Country (2027-2032) & (M units) Table 52. Europe Sclerotherapy Injection Needle Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M units) Table 53. Europe Sclerotherapy Injection Needle Sales by Country (2021-2026) & (M units) Table 54. Europe Sclerotherapy Injection Needle Sales by Country (2027-2032) & (M units) Table 55. Asia Pacific Sclerotherapy Injection Needle Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M units) Table 56. Asia Pacific Sclerotherapy Injection Needle Sales by Country (2021-2026) & (M units) Table 57. Asia Pacific Sclerotherapy Injection Needle Sales by Country (2027-2032) & (M units) Table 58. South America, Middle East and Africa Sclerotherapy Injection Needle Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M units) Table 59. South America, Middle East and Africa Sclerotherapy Injection Needle Sales by Country (2021-2026) & (M units) Table 60. South America, Middle East and Africa Sclerotherapy Injection Needle Sales by Country (2027-2032) & (M units) Table 61. Global Sclerotherapy Injection Needle Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Sclerotherapy Injection Needle Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Sclerotherapy Injection Needle Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Sclerotherapy Injection Needle Revenue Market Share by Region (2021-2026) Table 65. Global Sclerotherapy Injection Needle Revenue Market Share by Region (2027-2032) Table 66. Boston Scientific Company Information Table 67. Boston Scientific Business Overview Table 68. Boston Scientific Sclerotherapy Injection Needle Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Boston Scientific Sclerotherapy Injection Needle Product Portfolio Table 70. Boston Scientific Recent Development Table 71. ZKSK Medical Company Information Table 72. ZKSK Medical Business Overview Table 73. ZKSK Medical Sclerotherapy Injection Needle Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. ZKSK Medical Sclerotherapy Injection Needle Product Portfolio Table 75. ZKSK Medical Recent Development Table 76. Upex-med Company Information Table 77. Upex-med Business Overview Table 78. Upex-med Sclerotherapy Injection Needle Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Upex-med Sclerotherapy Injection Needle Product Portfolio Table 80. Upex-med Recent Development Table 81. TeleMed Systems Company Information Table 82. TeleMed Systems Business Overview Table 83. TeleMed Systems Sclerotherapy Injection Needle Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. TeleMed Systems Sclerotherapy Injection Needle Product Portfolio Table 85. TeleMed Systems Recent Development Table 86. STERIS Company Information Table 87. STERIS Business Overview Table 88. STERIS Sclerotherapy Injection Needle Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. STERIS Sclerotherapy Injection Needle Product Portfolio Table 90. STERIS Recent Development Table 91. Shaili Endoscopy Company Information Table 92. Shaili Endoscopy Business Overview Table 93. Shaili Endoscopy Sclerotherapy Injection Needle Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Shaili Endoscopy Sclerotherapy Injection Needle Product Portfolio Table 95. Shaili Endoscopy Recent Development Table 96. Micro-tech Company Information Table 97. Micro-tech Business Overview Table 98. Micro-tech Sclerotherapy Injection Needle Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Micro-tech Sclerotherapy Injection Needle Product Portfolio Table 100. Micro-tech Recent Development Table 101. Mednova Medical Technology Company Information Table 102. Mednova Medical Technology Business Overview Table 103. Mednova Medical Technology Sclerotherapy Injection Needle Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Mednova Medical Technology Sclerotherapy Injection Needle Product Portfolio Table 105. Mednova Medical Technology Recent Development Table 106. Jiangsu Vedkang Medical Company Information Table 107. Jiangsu Vedkang Medical Business Overview Table 108. Jiangsu Vedkang Medical Sclerotherapy Injection Needle Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Jiangsu Vedkang Medical Sclerotherapy Injection Needle Product Portfolio Table 110. Jiangsu Vedkang Medical Recent Development Table 111. Endo-Therapeutics Company Information Table 112. Endo-Therapeutics Business Overview Table 113. Endo-Therapeutics Sclerotherapy Injection Needle Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Endo-Therapeutics Sclerotherapy Injection Needle Product Portfolio Table 115. Endo-Therapeutics Recent Development Table 116. Diagmed Healthcare Company Information Table 117. Diagmed Healthcare Business Overview Table 118. Diagmed Healthcare Sclerotherapy Injection Needle Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Diagmed Healthcare Sclerotherapy Injection Needle Product Portfolio Table 120. Diagmed Healthcare Recent Development Table 121. Cook Medical Company Information Table 122. Cook Medical Business Overview Table 123. Cook Medical Sclerotherapy Injection Needle Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Cook Medical Sclerotherapy Injection Needle Product Portfolio Table 125. Cook Medical Recent Development Table 126. Conmed Corporation Company Information Table 127. Conmed Corporation Business Overview Table 128. Conmed Corporation Sclerotherapy Injection Needle Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Conmed Corporation Sclerotherapy Injection Needle Product Portfolio Table 130. Conmed Corporation Recent Development Table 131. ConMed Company Information Table 132. ConMed Business Overview Table 133. ConMed Sclerotherapy Injection Needle Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. ConMed Sclerotherapy Injection Needle Product Portfolio Table 135. ConMed Recent Development Table 136. Changzhou Jiuhong Medical Company Information Table 137. Changzhou Jiuhong Medical Business Overview Table 138. Changzhou Jiuhong Medical Sclerotherapy Injection Needle Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Changzhou Jiuhong Medical Sclerotherapy Injection Needle Product Portfolio Table 140. Changzhou Jiuhong Medical Recent Development Table 141. Blueneem Company Information Table 142. Blueneem Business Overview Table 143. Blueneem Sclerotherapy Injection Needle Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Blueneem Sclerotherapy Injection Needle Product Portfolio Table 145. Blueneem Recent Development Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Sclerotherapy Injection Needle Distributors List Table 149. Sclerotherapy Injection Needle Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Sclerotherapy Injection Needle Product Image Figure 2. Global Sclerotherapy Injection Needle Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sclerotherapy Injection Needle Market Size (2021-2032) & (US$ Million) Figure 4. Global Sclerotherapy Injection Needle Sales (2021-2032) & (M units) Figure 5. Global Sclerotherapy Injection Needle Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Sclerotherapy Injection Needle Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 21G Needle Image Figure 9. 23G Needle Image Figure 10. 24G Needle Image Figure 11. 25G Needle Image Figure 12. Others Image Figure 13. Global Sclerotherapy Injection Needle Sales by Type (2021 VS 2025 VS 2032) & (M units) Figure 14. Global Sclerotherapy Injection Needle Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Sclerotherapy Injection Needle Sales Market Share by Type (2021-2032) Figure 16. Global Sclerotherapy Injection Needle Revenue by Type (2021 VS 2025 VS 2032) & (M units) Figure 17. Global Sclerotherapy Injection Needle Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Sclerotherapy Injection Needle Revenue Market Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Others Image Figure 22. Global Sclerotherapy Injection Needle Sales by Application (2021 VS 2025 VS 2032) & (M units) Figure 23. Global Sclerotherapy Injection Needle Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Sclerotherapy Injection Needle Sales Market Share by Application (2021-2032) Figure 25. Global Sclerotherapy Injection Needle Revenue by Application (2021 VS 2025 VS 2032) & (M units) Figure 26. Global Sclerotherapy Injection Needle Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Sclerotherapy Injection Needle Revenue Market Share by Application (2021-2032) Figure 28. North America Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 29. North America Sclerotherapy Injection Needle Sales Market Share by Country (2021-2032) Figure 30. U.S. Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 31. Canada Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 32. Mexico Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 33. Europe Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 34. Europe Sclerotherapy Injection Needle Sales Market Share by Country (2021-2032) Figure 35. Germany Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 36. France Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 37. U.K. Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 38. Italy Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 39. Netherlands Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 40. Asia Pacific Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 41. Asia Pacific Sclerotherapy Injection Needle Sales Market Share by Country (2021-2032) Figure 42. China Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 43. Japan Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 44. South Korea Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 45. Southeast Asia Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 46. India Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 47. Australia Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 48. South America, Middle East and Africa Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 49. South America, Middle East and Africa Sclerotherapy Injection Needle Sales Market Share by Country (2021-2032) Figure 50. Brazil Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 51. South Africa Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 52. Saudi Arabia Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 53. Turkey Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 54. Argentina Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 55. UAE Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 56. Egypt Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 57. Chile Sclerotherapy Injection Needle Sales and Growth Rate (2021-2032) & (M units) Figure 58. Global Sclerotherapy Injection Needle Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Sclerotherapy Injection Needle Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Sclerotherapy Injection Needle Revenue (2021-2032) & (US$ Million) Figure 61. North America Sclerotherapy Injection Needle Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Sclerotherapy Injection Needle Revenue (2021-2032) & (US$ Million) Figure 63. Europe Sclerotherapy Injection Needle Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Sclerotherapy Injection Needle Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Sclerotherapy Injection Needle Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Sclerotherapy Injection Needle Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Sclerotherapy Injection Needle Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Sclerotherapy Injection Needle Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Sclerotherapy Injection Needle Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 21G Needle
  • 23G Needle
  • 24G Needle
  • 25G Needle
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Boston Scientific
  • ZKSK Medical
  • Upex-med
  • TeleMed Systems
  • STERIS
  • Shaili Endoscopy
  • Micro-tech
  • Mednova Medical Technology
  • Jiangsu Vedkang Medical
  • Endo-Therapeutics
  • Diagmed Healthcare
  • Cook Medical
  • Conmed Corporation
  • ConMed
  • Changzhou Jiuhong Medical
  • Blueneem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sclerotherapy Injection Needle Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sclerotherapy Injection Needle Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Sclerotherapy Injection Needle Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Sclerotherapy Injection Needle Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Sclerotherapy Injection Needle Market Dynamics
  1. 2.1 Sclerotherapy Injection Needle Industry Trends
  2. 2.2 Sclerotherapy Injection Needle Industry Drivers
  3. 2.3 Sclerotherapy Injection Needle Industry Opportunities and Challenges
  4. 2.4 Sclerotherapy Injection Needle Industry Restraints
3 Sclerotherapy Injection Needle Market by Manufacturers
  1. 3.1 Global Sclerotherapy Injection Needle Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Sclerotherapy Injection Needle Sales by Manufacturers (2021-2026)
  3. 3.3 Global Sclerotherapy Injection Needle Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Sclerotherapy Injection Needle Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sclerotherapy Injection Needle Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Sclerotherapy Injection Needle Manufacturers, Product Type & Application
  7. 3.7 Global Sclerotherapy Injection Needle Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sclerotherapy Injection Needle Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sclerotherapy Injection Needle Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sclerotherapy Injection Needle Tier 1, Tier 2, and Tier 3
4 Sclerotherapy Injection Needle Market by Type
  1. 4.1 Sclerotherapy Injection Needle Type Introduction
  2. 4.1.1 21G Needle
  3. 4.1.2 23G Needle
  4. 4.1.3 24G Needle
  5. 4.1.4 25G Needle
  6. 4.1.5 Others
  7. 4.2 Global Sclerotherapy Injection Needle Sales by Type
  8. 4.2.1 Global Sclerotherapy Injection Needle Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Sclerotherapy Injection Needle Sales by Type (2021-2032)
  10. 4.2.3 Global Sclerotherapy Injection Needle Sales Market Share by Type (2021-2032)
  11. 4.3 Global Sclerotherapy Injection Needle Revenue by Type
  12. 4.3.1 Global Sclerotherapy Injection Needle Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Sclerotherapy Injection Needle Revenue by Type (2021-2032)
  14. 4.3.3 Global Sclerotherapy Injection Needle Revenue Market Share by Type (2021-2032)
5 Sclerotherapy Injection Needle Market by Application
  1. 5.1 Sclerotherapy Injection Needle Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Sclerotherapy Injection Needle Sales by Application
  6. 5.2.1 Global Sclerotherapy Injection Needle Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sclerotherapy Injection Needle Sales by Application (2021-2032)
  8. 5.2.3 Global Sclerotherapy Injection Needle Sales Market Share by Application (2021-2032)
  9. 5.3 Global Sclerotherapy Injection Needle Revenue by Application
  10. 5.3.1 Global Sclerotherapy Injection Needle Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Sclerotherapy Injection Needle Revenue by Application (2021-2032)
  12. 5.3.3 Global Sclerotherapy Injection Needle Revenue Market Share by Application (2021-2032)
6 Global Sclerotherapy Injection Needle Sales by Region
  1. 6.1 Global Sclerotherapy Injection Needle Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sclerotherapy Injection Needle Sales by Region (2021-2032)
  3. 6.2.1 Global Sclerotherapy Injection Needle Sales by Region (2021-2026)
  4. 6.2.2 Global Sclerotherapy Injection Needle Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sclerotherapy Injection Needle Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Sclerotherapy Injection Needle Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Sclerotherapy Injection Needle Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Sclerotherapy Injection Needle Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Sclerotherapy Injection Needle Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Sclerotherapy Injection Needle Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Sclerotherapy Injection Needle Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Sclerotherapy Injection Needle Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Sclerotherapy Injection Needle Revenue by Region
  1. 7.1 Global Sclerotherapy Injection Needle Revenue by Region
  2. 7.1.1 Global Sclerotherapy Injection Needle Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Sclerotherapy Injection Needle Revenue by Region (2021-2026)
  4. 7.1.3 Global Sclerotherapy Injection Needle Revenue by Region (2027-2032)
  5. 7.1.4 Global Sclerotherapy Injection Needle Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Sclerotherapy Injection Needle Revenue (2021-2032)
  8. 7.2.2 North America Sclerotherapy Injection Needle Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Sclerotherapy Injection Needle Revenue (2021-2032)
  11. 7.3.2 Europe Sclerotherapy Injection Needle Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Sclerotherapy Injection Needle Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Sclerotherapy Injection Needle Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Sclerotherapy Injection Needle Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Sclerotherapy Injection Needle Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Boston Scientific
  2. 8.1.1 Boston Scientific Company Information
  3. 8.1.2 Boston Scientific Business Overview
  4. 8.1.3 Boston Scientific Sclerotherapy Injection Needle Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boston Scientific Sclerotherapy Injection Needle Product Portfolio
  6. 8.1.5 Boston Scientific Recent Developments
  7. 8.2 ZKSK Medical
  8. 8.2.1 ZKSK Medical Company Information
  9. 8.2.2 ZKSK Medical Business Overview
  10. 8.2.3 ZKSK Medical Sclerotherapy Injection Needle Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ZKSK Medical Sclerotherapy Injection Needle Product Portfolio
  12. 8.2.5 ZKSK Medical Recent Developments
  13. 8.3 Upex-med
  14. 8.3.1 Upex-med Company Information
  15. 8.3.2 Upex-med Business Overview
  16. 8.3.3 Upex-med Sclerotherapy Injection Needle Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Upex-med Sclerotherapy Injection Needle Product Portfolio
  18. 8.3.5 Upex-med Recent Developments
  19. 8.4 TeleMed Systems
  20. 8.4.1 TeleMed Systems Company Information
  21. 8.4.2 TeleMed Systems Business Overview
  22. 8.4.3 TeleMed Systems Sclerotherapy Injection Needle Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 TeleMed Systems Sclerotherapy Injection Needle Product Portfolio
  24. 8.4.5 TeleMed Systems Recent Developments
  25. 8.5 STERIS
  26. 8.5.1 STERIS Company Information
  27. 8.5.2 STERIS Business Overview
  28. 8.5.3 STERIS Sclerotherapy Injection Needle Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 STERIS Sclerotherapy Injection Needle Product Portfolio
  30. 8.5.5 STERIS Recent Developments
  31. 8.6 Shaili Endoscopy
  32. 8.6.1 Shaili Endoscopy Company Information
  33. 8.6.2 Shaili Endoscopy Business Overview
  34. 8.6.3 Shaili Endoscopy Sclerotherapy Injection Needle Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shaili Endoscopy Sclerotherapy Injection Needle Product Portfolio
  36. 8.6.5 Shaili Endoscopy Recent Developments
  37. 8.7 Micro-tech
  38. 8.7.1 Micro-tech Company Information
  39. 8.7.2 Micro-tech Business Overview
  40. 8.7.3 Micro-tech Sclerotherapy Injection Needle Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Micro-tech Sclerotherapy Injection Needle Product Portfolio
  42. 8.7.5 Micro-tech Recent Developments
  43. 8.8 Mednova Medical Technology
  44. 8.8.1 Mednova Medical Technology Company Information
  45. 8.8.2 Mednova Medical Technology Business Overview
  46. 8.8.3 Mednova Medical Technology Sclerotherapy Injection Needle Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Mednova Medical Technology Sclerotherapy Injection Needle Product Portfolio
  48. 8.8.5 Mednova Medical Technology Recent Developments
  49. 8.9 Jiangsu Vedkang Medical
  50. 8.9.1 Jiangsu Vedkang Medical Company Information
  51. 8.9.2 Jiangsu Vedkang Medical Business Overview
  52. 8.9.3 Jiangsu Vedkang Medical Sclerotherapy Injection Needle Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Jiangsu Vedkang Medical Sclerotherapy Injection Needle Product Portfolio
  54. 8.9.5 Jiangsu Vedkang Medical Recent Developments
  55. 8.10 Endo-Therapeutics
  56. 8.10.1 Endo-Therapeutics Company Information
  57. 8.10.2 Endo-Therapeutics Business Overview
  58. 8.10.3 Endo-Therapeutics Sclerotherapy Injection Needle Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Endo-Therapeutics Sclerotherapy Injection Needle Product Portfolio
  60. 8.10.5 Endo-Therapeutics Recent Developments
  61. 8.11 Diagmed Healthcare
  62. 8.11.1 Diagmed Healthcare Company Information
  63. 8.11.2 Diagmed Healthcare Business Overview
  64. 8.11.3 Diagmed Healthcare Sclerotherapy Injection Needle Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Diagmed Healthcare Sclerotherapy Injection Needle Product Portfolio
  66. 8.11.5 Diagmed Healthcare Recent Developments
  67. 8.12 Cook Medical
  68. 8.12.1 Cook Medical Company Information
  69. 8.12.2 Cook Medical Business Overview
  70. 8.12.3 Cook Medical Sclerotherapy Injection Needle Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Cook Medical Sclerotherapy Injection Needle Product Portfolio
  72. 8.12.5 Cook Medical Recent Developments
  73. 8.13 Conmed Corporation
  74. 8.13.1 Conmed Corporation Company Information
  75. 8.13.2 Conmed Corporation Business Overview
  76. 8.13.3 Conmed Corporation Sclerotherapy Injection Needle Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Conmed Corporation Sclerotherapy Injection Needle Product Portfolio
  78. 8.13.5 Conmed Corporation Recent Developments
  79. 8.14 ConMed
  80. 8.14.1 ConMed Company Information
  81. 8.14.2 ConMed Business Overview
  82. 8.14.3 ConMed Sclerotherapy Injection Needle Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 ConMed Sclerotherapy Injection Needle Product Portfolio
  84. 8.14.5 ConMed Recent Developments
  85. 8.15 Changzhou Jiuhong Medical
  86. 8.15.1 Changzhou Jiuhong Medical Company Information
  87. 8.15.2 Changzhou Jiuhong Medical Business Overview
  88. 8.15.3 Changzhou Jiuhong Medical Sclerotherapy Injection Needle Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Changzhou Jiuhong Medical Sclerotherapy Injection Needle Product Portfolio
  90. 8.15.5 Changzhou Jiuhong Medical Recent Developments
  91. 8.16 Blueneem
  92. 8.16.1 Blueneem Company Information
  93. 8.16.2 Blueneem Business Overview
  94. 8.16.3 Blueneem Sclerotherapy Injection Needle Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Blueneem Sclerotherapy Injection Needle Product Portfolio
  96. 8.16.5 Blueneem Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sclerotherapy Injection Needle Value Chain Analysis
  2. 9.1.1 Sclerotherapy Injection Needle Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sclerotherapy Injection Needle Production Mode & Process
  6. 9.2 Sclerotherapy Injection Needle Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sclerotherapy Injection Needle Distributors
  9. 9.2.3 Sclerotherapy Injection Needle Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst